Related Videos
Video
Advances (and Uncertainties) in Oncology: Current and Future Roles of Antibody Drug Conjugates
Focusing on common bladder, lung and breast cancers, three UCSF oncologists describe how antibody drug conjugates (ADCs) are changing the treatment landscape, especially for refractory cases
Video
Better Cancer Care: Pearls From the Best Studies of 2022
Focusing on blood, breast and lung cancers, our specialists deliver exciting findings from the latest phase III trials.
